Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux

CNS oncology

Volumn 2, Issue 3, 2013, Pages 271-288

  Lin, Fan ^a   de Gooijer, Mark C ^a   Hanekamp, Diana ^a   Brandsma, Dieta ^a   Beijnen, Jos H ^a   van Tellingen, Olaf ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN NEOPLASMS; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; DRUG RESISTANCE; GENETICS; GLIOMA; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84901001579     PISSN: None     EISSN: 20450915     Source Type: Journal    
DOI: 10.2217/cns.13.15     Document Type: Review

References (0)